Efficacy and Tolerability of Tasipimidine in Sleepless Patients

NCT06956495 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Tasipimidine
DRUG: Tasipimidine placebo

Sponsor

Orion Corporation, Orion Pharma

Collaborators

[object Object]